Akums Drugs & Pharmaceuticals reports consolidated net profit of Rs 60.17 crore in the June 2024 quarter
Net profit of Akums Drugs & Pharmaceuticals reported to Rs 60.17 crore in the quarter ended June 2024 as against net loss of Rs 188.23 crore during the previous quarter ended June 2023. Sales rose 5.07% to Rs 1019.11 crore in the quarter ended June 2024 as against Rs 969.89 crore during the previous quarter ended June 2023.
Particulars | Quarter Ended | ||
Jun. 2024 | Jun. 2023 | % Var. | |
Sales | 1019.11 | 969.89 | 5 |
OPM % | 12.56 | -12.92 | - |
PBDT | 121.54 | -129.33 | LP |
PBT | 87.48 | -159.04 | LP |
NP | 60.17 | -188.23 | LP |
What is the Bombay Stock Exchange?
10 mins read . Dec 9, 2024
Stocks Under 5 Rupees in India
13 mins read . Dec 9, 2024
Stocks Under 1000 Rupees in India
14 mins read . Dec 6, 2024
Explore our products
₹0 Brokerage *
Open Demat Account